| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.5M | +52.3% |
| SG&A Expense | $77.7M | +92.5% |
| Operating Income | -$145.2M | -112.7% |
| Interest Expense | $0 | -100.0% |
| Income Tax | $0 | — |
| Net Income | -$140.0M | -101.2% |
| EPS (Basic) | -$5.49 | -75.4% |
| EPS (Diluted) | -$5.49 | -75.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $161.9M | -52.6% |
| Current Assets | $383.8M | -13.2% |
| Total Assets | $558.5M | -10.8% |
| Current Liabilities | $28.8M | +12.1% |
| Total Liabilities | $36.2M | +10.7% |
| Stockholders' Equity | $522.2M | -12.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$100.6M | -109.8% |
| Capital Expenditures | $53.0M | -22.5% |
| Investing Cash Flow | -$114.1M | +49.7% |
| Financing Cash Flow | $35.3M | -89.8% |
| Free Cash Flow | -$153.5M | -32.1% |